SCHEMBL4088362

SCHEMBL4088362

CC(C)c1cc(O)c(O)c(-c2nnc(S)n2-c2ccc3[nH]ccc3c2)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP3K11 Q16584 5/20 0.37
GUSB P08236 5/20 0.35
GABRP O00591 1/20 0.34
GABRD O14764 1/20 0.34
GABRA1 P14867 1/20 0.34
GABRB1 P18505 1/20 0.34
GABRG2 P18507 1/20 0.34
GABRB3 P28472 1/20 0.34
GABRA5 P31644 1/20 0.34
GABRA3 P34903 1/20 0.34
GABRA2 P47869 1/20 0.34
GABRB2 P47870 1/20 0.34
GABRA4 P48169 1/20 0.34
GABRE P78334 1/20 0.34
GABRA6 Q16445 1/20 0.34
GABRG1 Q8N1C3 1/20 0.34
GABRG3 Q99928 1/20 0.34
GABRQ Q9UN88 1/20 0.34
HSP90AA1 P07900 5/20 0.32
HSP90AB1 P08238 5/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL421210 0.83 HSP90AA1 (0.48) HSP90AA1HSP90AB1
SCHEMBL12694836 0.77 MAP3K11 (0.39) MAP3K11GUSBGABRPGABRDGABRA1
SCHEMBL4083284 0.75 HSP90AA1 (0.36) HSP90AA1HSP90AB1
SCHEMBL20879033 0.72 HSP90AA1 (0.49) HSP90AA1HSP90AB1
SCHEMBL3989106 0.69 HSP90AA1 (0.55) HSP90AA1HSP90AB1
SCHEMBL15940182 0.69 HSP90AA1 (0.48) HSP90AA1HSP90AB1
SCHEMBL1861797 0.68 HSP90AA1 (0.47) HSP90AA1HSP90AB1
SCHEMBL14342490 0.66 HSP90AA1 (0.69) HSP90AA1HSP90AB1
SCHEMBL3915279 0.66 HSP90AA1 (0.45) HSP90AA1HSP90AB1
SCHEMBL3094973 0.66 HSP90AA1 (0.45) HSP90AA1HSP90AB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2054059-A2 TRIAZOLE COMPOUNDS THAT MODULATE HSP90 ACTIVITY Synta Pharmaceuticals Corporation (US) 2009-05-06 EP disclosed
WO-2008021364-A2 TRIAZOLE COMPOUNDS THAT MODULATE HSP90 ACTIVITY SYNTA PHARMACEUTICALS CORP. (US) 2008-02-21 WO disclosed